Free Biopharma Stock Content

Let's review moves from smid-cap biopharma companies during this past week. See Table 1 for weekly moves and moves YTD for companies and...

TGTX BRIUMVI (Ublituximab) approved for MS on 12/28/2022! See the new label: https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/76...

Let's review moves from smid-cap biopharma companies during this past week. See Table 1 for weekly moves and moves YTD for companies and...

Last week we saw the MDGL NASH data on Monday and it's up over +300%. This next week we see LOTS of PDUFA events happening to close out...

Summary: Esperion CLEAR outcomes data came out Dec 7 This was a month early and stock did not react well (down 15% on 12/7 and 32% that...

We're winding down to the end of 2022 but still have lots of major readouts left with year. This includes readouts from companies like...

Let's review moves from smid-cap biopharma companies during this past week. See Table 1 for weekly moves and moves YTD for companies and...

Let's review moves from smid-cap biopharma companies during this past week. See Table 1 for weekly moves and moves YTD for companies and...

(Last updated 12/15/22) The 41st Annual J.P. Morgan Health Care Conference is taking place in San Francisco, AC from January 9-12, 2023. ...

(First posted 12/15/22) NASH is a liver disease that is one of the most challenging diseases for finding effective therapeutics. There...

There are a number of biotech catalyst events left in 2022, including FDA/PDUFA events, data readouts, and biomedical meetings. See the...

Let's review moves from smid-cap biopharma companies during this past week. See Table 1 for weekly moves and moves YTD for companies and...

Let's review moves from smid-cap biopharma companies during this past week. See Table 1 for weekly moves and moves YTD for companies and...

Let's review moves from smid-cap biopharma companies during this past week. See Table 1 for weekly moves and moves YTD for companies and...

Let's review moves from smid-cap biopharma companies during this past week. See Table 1 for weekly moves and moves YTD for companies and...

Summary: Several companies have already announced presentations at SABCS 2022 (San Antonio Breast Cancer Symposium) Abstracts will...

Last updated 2/24/23 Summary: Hedge fund holdings can help you discover new investment ideas See further detailed analysis of all 36...

SUMMARY The drug-price reform focus of Congress affects biopharma stock prices The likelihood that Republicans will control at least the...

Let's review moves from smid-cap biopharma companies during this past week. See Table 1 for weekly moves and moves YTD for companies and...

Let's review moves from smid-cap biopharma companies during this past week. See Table 1 for weekly moves and moves YTD for companies and...